• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腹主动脉瘤血管内修复术的全州经验:迅速普及且早期效果极佳。

A statewide experience with endovascular abdominal aortic aneurysm repair: rapid diffusion with excellent early results.

作者信息

Anderson Patrice L, Arons Raymond R, Moskowitz Alan J, Gelijns Annetine, Magnell Corey, Faries Peter L, Clair Dan, Nowygrod Roman, Kent K Craig

机构信息

International Center for Health Outcomes and Innovation Research, College of Physicians and Surgeons, and Mailman School of Public Health, Columbia University, 600 W. 168th Street, 7th Floor, New York, NY 10032, USA.

出版信息

J Vasc Surg. 2004 Jan;39(1):10-9. doi: 10.1016/j.jvs.2003.07.020.

DOI:10.1016/j.jvs.2003.07.020
PMID:14718804
Abstract

OBJECTIVE

The purpose of this study was to compare survival and outcomes of endovascular versus open repair of abdominal aortic aneurysms (AAAs) in New York State (NYS).

METHODS

We used the NYS discharge dataset Statewide Planning and Research Cooperative System (SPARCS) to analyze the outcomes of elective admission for nonruptured (International Classification of Diseases-9th revision [ICD-9] 441.4) open aneurysm repair (38.44) and endovascular aneurysm repair (39.71) during the years 2000-2002. The ICD-9 code for endovascular repair was introduced in late 2000, thus capturing 3 months of empiric data for 2000.

RESULTS

There has been a significant increase in the number of AAA procedures performed in NYS (comparing before and after 2000: average, 1419 vs 1701; P =.0001), temporally coinciding with the implementation of training programs after US Food and Drug Administration approval of endovascular grafts and the new payment code. From 2000 to 2002 the number of NYS hospitals performing endovascular repairs increased from 24 to 60. By 2002 there were more endovascular repairs being performed than open repairs (871 vs 783). The target population for these surgical interventions showed interesting differences. In 2002, women had a 43% chance of receiving an endograft, whereas men had a 55% probability. The use of endovascular repair over the observation period was relatively constant in patients younger than 65 years. In patients older than 65 years, and especially those older than 75 years, endovascular use increased substantially, so that by 2002 older patients were more likely to undergo endovascular repair than open repair. Patients who underwent endovascular repair had significantly more hypertension, coronary artery disease, diabetes, and hyperlipidemia than did patients who underwent open repair. Yet the mean length of stay for endovascular procedures was approximately 3.6 days, and for open procedures was about 10.3 days, across all 3 years (P = <.0001). Moreover, patients who underwent endovascular repair had statistically fewer postoperative complications and significantly lower mortality. In-hospital mortality in 2001 was 3.55% for open repair and 1.14% for endovascular repair (P =.0018), and in 2002 these rates were 4.21% versus 0.8% (P <.0001), respectively.

CONCLUSION

This dataset suggests that endovascular AAA repairs are being performed in a patient population with a higher frequency of comorbidities. However, endovascular repairs still are associated with significantly lower in-hospital mortality, fewer postoperative complications, and a dramatically shorter length of stay. These results suggest that, despite the rapid diffusion of this new technique, early perioperative outcomes may be superior to those with conventional open repair. However, prospective clinical studies are needed to confirm these insights, and such studies may require the infrastructure of consortia of hospitals or society-based registries.

摘要

目的

本研究旨在比较纽约州腹主动脉瘤(AAA)血管内修复术与开放修复术的生存率及治疗结果。

方法

我们使用纽约州出院数据集全州规划与研究合作系统(SPARCS),分析2000 - 2002年间非破裂性腹主动脉瘤(国际疾病分类第九版[ICD - 9] 441.4)开放动脉瘤修复术(38.44)和血管内动脉瘤修复术(39.71)的择期入院治疗结果。血管内修复术的ICD - 9编码于2000年末引入,因此获取了2000年3个月的经验数据。

结果

纽约州进行的AAA手术数量显著增加(比较2000年前后:平均分别为1419例和1701例;P = 0.0001),这在时间上与美国食品药品监督管理局批准血管内移植物及新支付编码后实施的培训项目相吻合。从2000年到2002年,纽约州进行血管内修复术的医院数量从24家增加到60家。到2002年,进行血管内修复术的数量超过了开放修复术(871例对783例)。这些手术干预的目标人群存在有趣的差异。2002年,女性接受血管内移植物治疗的几率为43%,而男性为55%。在65岁以下的患者中,观察期内血管内修复术的使用相对稳定。在65岁以上的患者中,尤其是75岁以上的患者,血管内修复术的使用大幅增加,以至于到2002年,老年患者接受血管内修复术的可能性高于开放修复术。接受血管内修复术的患者比接受开放修复术的患者患有更多的高血压、冠状动脉疾病、糖尿病和高脂血症。然而,在这3年中,血管内手术的平均住院时间约为3.6天,开放手术约为10.3天(P = <0.0001)。此外,接受血管内修复术的患者术后并发症在统计学上更少,死亡率显著更低。2001年开放修复术的院内死亡率为3.55%,血管内修复术为1.14%(P = 0.0018),2002年这些比率分别为4.21%对0.8%(P <0.0001)。

结论

该数据集表明,血管内AAA修复术正在合并症发生率较高的患者群体中进行。然而,血管内修复术仍与显著更低的院内死亡率、更少的术后并发症以及显著更短的住院时间相关。这些结果表明,尽管这项新技术迅速普及,但围手术期早期结果可能优于传统开放修复术。然而,需要前瞻性临床研究来证实这些观点,此类研究可能需要医院联合体或基于社会的登记系统的基础设施。

相似文献

1
A statewide experience with endovascular abdominal aortic aneurysm repair: rapid diffusion with excellent early results.腹主动脉瘤血管内修复术的全州经验:迅速普及且早期效果极佳。
J Vasc Surg. 2004 Jan;39(1):10-9. doi: 10.1016/j.jvs.2003.07.020.
2
Women derive less benefit from elective endovascular aneurysm repair than men.女性从择期血管内动脉瘤修复中获益不如男性。
J Vasc Surg. 2012 Apr;55(4):906-13. doi: 10.1016/j.jvs.2011.11.047. Epub 2012 Feb 8.
3
Perioperative outcomes after open and endovascular repair of intact abdominal aortic aneurysms in the United States during 2001.2001年美国完整腹主动脉瘤开放修复术和血管腔内修复术后的围手术期结局
J Vasc Surg. 2004 Mar;39(3):491-6. doi: 10.1016/j.jvs.2003.12.001.
4
Therapy of renal artery aneurysms in New York State: outcomes of patients undergoing open and endovascular repair.纽约州肾动脉瘤的治疗:接受开放手术和血管腔内修复的患者的治疗结果
Ann Vasc Surg. 2009 Mar;23(2):194-200. doi: 10.1016/j.avsg.2008.10.002. Epub 2008 Dec 6.
5
Long-term outcomes and resource utilization of endovascular versus open repair of abdominal aortic aneurysms in Ontario.安大略省腹主动脉瘤腔内修复与开放修复的长期结局和资源利用比较。
J Vasc Surg. 2010 Mar;51(3):577-83, 583.e1-3. doi: 10.1016/j.jvs.2009.10.101. Epub 2010 Jan 4.
6
Identifying patients with AAA with the highest risk following endovascular repair.识别血管内修复术后风险最高的腹主动脉瘤患者。
Vasc Endovascular Surg. 2012 Aug;46(6):455-9. doi: 10.1177/1538574412450752. Epub 2012 Jun 18.
7
Evaluation of the complexity of open abdominal aneurysm repair in the era of endovascular stent grafting.血管内支架移植物时代开放性腹主动脉瘤修复术的复杂性评估。
J Vasc Surg. 2006 May;43(5):915-20; discussion 920. doi: 10.1016/j.jvs.2006.01.017.
8
Measure what matters: institutional outcome data are superior to the use of surrogate markers to define "center of excellence" for abdominal aortic aneurysm repair.衡量关键指标:机构结局数据优于使用替代指标来定义腹主动脉瘤修复的“卓越中心”。
Ann Vasc Surg. 2008 May-Jun;22(3):328-34. doi: 10.1016/j.avsg.2007.09.013. Epub 2008 Apr 14.
9
A decade of change in abdominal aortic aneurysm repair in the United States: Have we improved outcomes equally between men and women?美国腹主动脉瘤修复十年变迁:我们是否在同等程度上改善了男性和女性的治疗效果?
J Vasc Surg. 2006 Feb;43(2):230-8; discussion 238. doi: 10.1016/j.jvs.2005.09.043.
10
Graft infection after endovascular abdominal aortic aneurysm repair.血管内腹主动脉瘤修复术后移植物感染。
J Vasc Surg. 2011 Jul;54(1):58-63. doi: 10.1016/j.jvs.2010.11.111. Epub 2011 Feb 2.

引用本文的文献

1
Analysis of Mortality-Related Factors in Patients Aged >80 Years Treated for Abdominal Aortic Aneurysms.80岁以上腹主动脉瘤患者死亡相关因素分析
J Chest Surg. 2025 Sep 5;58(5):196-204. doi: 10.5090/jcs.25.003. Epub 2025 Aug 7.
2
The Justification of Open Surgical Repair for an Abdominal Aortic Aneurysm: A Retrospective Comparison of Outcomes of Endovascular Aneurysm Repair and a Brief Review of the Literature.腹主动脉瘤开放手术修复的合理性:血管内动脉瘤修复术结果的回顾性比较及文献简要综述
Life (Basel). 2025 Mar 8;15(3):426. doi: 10.3390/life15030426.
3
Comprehensive bioinformatics analysis revealed potential key genes and pathways underlying abdominal aortic aneurysm.
全面的生物信息学分析揭示了腹主动脉瘤潜在的关键基因和通路。
Comput Struct Biotechnol J. 2023 Nov 2;21:5423-5433. doi: 10.1016/j.csbj.2023.10.052. eCollection 2023.
4
Outcomes after Elective Abdominal Aortic Aneurysm Repair Have Improved Over Time in Patients on Dialysis.透析患者择期腹主动脉瘤修复术后的结局随时间推移而改善。
Ann Vasc Surg. 2022 Oct;86:94-103. doi: 10.1016/j.avsg.2022.05.016. Epub 2022 Jun 6.
5
Mortality following elective abdominal aortic aneurysm repair in women.女性择期腹主动脉瘤修复术后的死亡率。
Br J Surg. 2022 Mar 15;109(4):340-345. doi: 10.1093/bjs/znab465.
6
Abdominal Aortic Aneurysm Formation with a Focus on Vascular Smooth Muscle Cells.腹主动脉瘤的形成,重点关注血管平滑肌细胞
Life (Basel). 2022 Jan 27;12(2):191. doi: 10.3390/life12020191.
7
Intra-arterial catheter-directed CT angiography for assessment of endovascular aortic aneurysm repair.经动脉导管 CT 血管造影评估血管内主动脉瘤修复术。
PLoS One. 2019 Sep 10;14(9):e0221375. doi: 10.1371/journal.pone.0221375. eCollection 2019.
8
[Interventional endovascular therapy of infrarenal abdominal aortic aneurysm].[肾下腹主动脉瘤的介入血管内治疗]
Radiologe. 2013 Jun;53(6):503-12. doi: 10.1007/s00117-012-2451-8.
9
The Endurant Stent Graft System: 15-month follow-up report in patients with challenging abdominal aortic anatomies.Endurant 支架移植物系统:在具有挑战性的腹主动脉解剖结构的患者中的 15 个月随访报告。
Langenbecks Arch Surg. 2011 Aug;396(6):801-10. doi: 10.1007/s00423-011-0806-7. Epub 2011 May 25.
10
Defining perioperative mortality after open and endovascular aortic aneurysm repair in the US Medicare population.在美国 Medicare 人群中定义开放式和血管内主动脉瘤修复术后的围手术期死亡率。
J Am Coll Surg. 2011 Mar;212(3):349-55. doi: 10.1016/j.jamcollsurg.2010.12.003. Epub 2011 Feb 4.